PAUGET, Bertrand; PARISOT, Xavier - In: Scientific Bulletin - Economic Sciences 12 (2013) 2, pp. 85-94
There is in France and more generally in Europe a paradox. In the agro industry business, the use of biotechnology is suspicious and controversy (see for example the emblematic case of GMOs), the subject is little debate in the health sector. Yet, in those two sectors, the production process of...